Literature DB >> 12097319

p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage.

Jian Ren1, Rakesh Datta, Hisashi Shioya, Yongqing Li, Eiji Oki, Verena Biedermann, Ajit Bharti, Donald Kufe.   

Abstract

Protein kinase C (PKC) delta is cleaved by caspase-3 to a kinase-active catalytic fragment (PKCdeltaCF) in the apoptotic response of cells to DNA damage. Expression of PKCdeltaCF contributes to the induction of apoptosis by mechanisms that are presently unknown. Here we demonstrate that PKCdeltaCF associates with p73beta, a structural and functional homologue of the p53 tumor suppressor. The results show that PKCdeltaCF phosphorylates the p73beta transactivation and DNA-binding domains. One PKCdeltaCF-phosphorylation site has been mapped to Ser-289 in the p73beta DNA-binding domain. PKCdeltaCF-mediated phosphorylation of p73beta is associated with accumulation of p73beta and induction of p73beta-mediated transactivation. By contrast, PKCdeltaCF-induced activation of p73beta is attenuated by mutating Ser-289 to Ala (S289A). The results also demonstrate that PKCdeltaCF stimulates p73beta-mediated apoptosis and that this response is attenuated with the p73beta(S289A) mutant. These findings demonstrate that cleavage of PKCdelta to PKCdeltaCF induces apoptosis by a mechanism in part dependent on PKCdeltaCF-mediated phosphorylation of the p73beta Ser-289 site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097319     DOI: 10.1074/jbc.M110667200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells.

Authors:  Niketa A Patel; Shijie S Song; Denise R Cooper
Journal:  Gene Expr       Date:  2006

2.  Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain.

Authors:  Ulrika Nyman; Pinelopi Vlachos; Anna Cascante; Ola Hermanson; Boris Zhivotovsky; Bertrand Joseph
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

Review 3.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 4.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

5.  Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells.

Authors:  Kaori Kato; Dai Yamanouchi; Karla Esbona; Kentaro Kamiya; Fan Zhang; K Craig Kent; Bo Liu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-16       Impact factor: 4.733

6.  AMPK couples p73 with p53 in cell fate decision.

Authors:  Y Adamovich; J Adler; V Meltser; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-05-30       Impact factor: 15.828

Review 7.  Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

Authors:  Anumantha Kanthasamy; Huajun Jin; Suneet Mehrotra; Rajakishore Mishra; Arthi Kanthasamy; Ajay Rana
Journal:  Neurotoxicology       Date:  2009-12-11       Impact factor: 4.294

8.  Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta.

Authors:  Rebecca L Cunningham; Andrea Giuffrida; James L Roberts
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

9.  Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras.

Authors:  T Zhu; T Tsuji; C Chen
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

10.  Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.

Authors:  Meng Zhao; Xu-Fang Duan; Xu-Yun Zhao; Bo Zhang; Ying Lu; Wei Liu; Jin-Ke Cheng; Guo-Qiang Chen
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.